PE20010110A1 - Derivados de 1,5-benzodiazepina como agonistas de los receptores cck-a - Google Patents

Derivados de 1,5-benzodiazepina como agonistas de los receptores cck-a

Info

Publication number
PE20010110A1
PE20010110A1 PE2000000415A PE0004152000A PE20010110A1 PE 20010110 A1 PE20010110 A1 PE 20010110A1 PE 2000000415 A PE2000000415 A PE 2000000415A PE 0004152000 A PE0004152000 A PE 0004152000A PE 20010110 A1 PE20010110 A1 PE 20010110A1
Authority
PE
Peru
Prior art keywords
cck
agonists
receptors
benzodiazepine derivatives
phenyl
Prior art date
Application number
PE2000000415A
Other languages
English (en)
Spanish (es)
Inventor
David Colclough
Jerzy Ryszard Szewczyk
Anne Hodgson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20010110A1 publication Critical patent/PE20010110A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2000000415A 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina como agonistas de los receptores cck-a PE20010110A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process

Publications (1)

Publication Number Publication Date
PE20010110A1 true PE20010110A1 (es) 2001-03-05

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000415A PE20010110A1 (es) 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina como agonistas de los receptores cck-a

Country Status (21)

Country Link
EP (1) EP1212305A2 (zh)
JP (1) JP2002544200A (zh)
KR (1) KR20020012567A (zh)
CN (1) CN1161345C (zh)
AR (1) AR022044A1 (zh)
AU (1) AU4754800A (zh)
BR (1) BR0010338A (zh)
CA (1) CA2370801A1 (zh)
CO (1) CO5170461A1 (zh)
CZ (1) CZ20013988A3 (zh)
HK (1) HK1046138A1 (zh)
HU (1) HUP0201181A3 (zh)
IL (1) IL146124A0 (zh)
MX (1) MXPA01011267A (zh)
MY (1) MY138319A (zh)
NO (1) NO20015397L (zh)
NZ (1) NZ515048A (zh)
PE (1) PE20010110A1 (zh)
PL (1) PL351546A1 (zh)
TR (1) TR200103169T2 (zh)
WO (1) WO2000068209A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
GEP20094723B (en) 2004-05-25 2009-07-10 Pfizer Prod Inc Tetraazabenzo [e] azulene derivatives and analogs thereof
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
JP2002544200A (ja) 2002-12-24
MXPA01011267A (es) 2002-05-06
MY138319A (en) 2009-05-29
WO2000068209A3 (en) 2001-03-01
WO2000068209A2 (en) 2000-11-16
BR0010338A (pt) 2002-02-13
EP1212305A2 (en) 2002-06-12
KR20020012567A (ko) 2002-02-16
TR200103169T2 (tr) 2002-04-22
HK1046138A1 (zh) 2002-12-27
CA2370801A1 (en) 2000-11-16
HUP0201181A3 (en) 2003-10-28
NZ515048A (en) 2004-01-30
CZ20013988A3 (cs) 2002-02-13
AR022044A1 (es) 2002-09-04
CO5170461A1 (es) 2002-06-27
IL146124A0 (en) 2002-07-25
AU4754800A (en) 2000-11-21
CN1161345C (zh) 2004-08-11
CN1362949A (zh) 2002-08-07
PL351546A1 (en) 2003-05-05
NO20015397D0 (no) 2001-11-05
HUP0201181A2 (hu) 2002-12-28
NO20015397L (no) 2001-11-05

Similar Documents

Publication Publication Date Title
AR006545A1 (es) Compuestos sustitutos de las catecolaminas, utiles como antagonistas beta3, composiciones farmaceuticas que los contienen y compuestos intermediarios deaplicacion exclusiva en la preparacion de dichos compuestos
Robertson et al. Structure-activity relationships of (arylalkyl) imidazole anticonvulsants: comparison of the (fluorenylalkyl) imidazoles with nafimidone and denzimol
PE20081557A1 (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
MY143834A (en) Thrombin receptor antagonists
UY26291A1 (es) Compuestos químicos xxii
MXPA02001764A (es) Compuestos heteropoliciclicos y su uso como antagonistas de receptor de glutamato metabotropico.
PE20000728A1 (es) Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
NZ598067A (en) Benzazepine derivatives useful as vasopressin antagonists
PE20040600A1 (es) Derivados de triazol como antagonistas del receptor de taquicinina
PE20010759A1 (es) Derivados de benzodiazepina como antagonistas del receptor de glutamato metabotropico
PE20020082A1 (es) Composicion farmaceutica que comprende un inhibidor de aldosterona-sintasa y un antagonista del receptor de angiotensina ii (at1)
AR045229A1 (es) 6-(2,2,2-trifluoroetilamino)-7 cloro-2,3,4,5- tetrahidro-1h- benzo [d] azepina como agonista del receptor 5- ht2c
PE20060627A1 (es) Derivados de pirazol condensado como agonistas de los receptores cannabinoides cb1 y/o cb2
IE53016B1 (en) Benzazepines and benzodiazepines
PE20010854A1 (es) USO DE DERIVADOS DE PIRIMIDINA 4 SUSTITUIDOS COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO mGluR1
PE20010118A1 (es) Compuestos imidazoles sustituidos como antagonistas de neuropeptido y
PE59999A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona-8-sustituidos
PE20011114A1 (es) Decahidro-isoquinolinas
IL190219A (en) Compounds which have activity at m1 receptor, pharmaceutical compositions comprising them, process for their preparation and use thereof in the manufacture of medicaments
AR033377A1 (es) Derivados de benzocicloalquilenilamina como antagonistas de receptores muscarinicos
TW200602024A (en) Constrained himbacine analogs as thrombin receptor antagonists
PE16399A1 (es) Compuestos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores
NO322571B1 (no) Kondenserte azepiner som vasopressinagonister
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
PE20010110A1 (es) Derivados de 1,5-benzodiazepina como agonistas de los receptores cck-a

Legal Events

Date Code Title Description
FC Refusal